(Q35031744)

5 August 2017

1 reference

title

Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors (English)

1 reference

5 August 2017

Bjarni Thjodleifsson

1

1 reference

5 August 2017

publication date

1 January 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

19

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

911-927

1 reference

The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies

5 August 2017

cites work

1 reference

12 December 2020

Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials

1 reference

12 December 2020

Seroprevalence of Helicobacter pylori in south Sweden and Iceland

1 reference

12 December 2020

Survey of primary care physicians' approach to gastroesophageal reflux disease in elderly patients

1 reference

12 December 2020

Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient

1 reference

12 December 2020

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

1 reference

12 December 2020

Prevalence of non-ulcer dyspepsia in the Japanese population

1 reference

12 December 2020

Optimizing acid suppression for treatment of acid-related diseases

1 reference

12 December 2020

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group

1 reference

12 December 2020

Factors associated with consulting medical or non-medical practitioners for dyspepsia: an australian population-based study.

1 reference

12 December 2020

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

1 reference

12 December 2020

Proton pump inhibitors: better acid suppression when taken before a meal than without a meal

1 reference

12 December 2020

Gastroesophageal reflux disease: extraesophageal manifestations and therapy.

1 reference

12 December 2020

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

1 reference

12 December 2020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

12 December 2020

Lack of a pharmacokinetic interaction between lansoprazole or pantoprazole and theophylline

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

Helicobacter pylori modulation of gastric acid.

1 reference

12 December 2020

Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring

1 reference

12 December 2020

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

1 reference

12 December 2020

Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study

1 reference

12 December 2020

Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis

1 reference

12 December 2020

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers

1 reference

12 December 2020

Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine

1 reference

12 December 2020

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group.

1 reference

12 December 2020

Differences in pH-dependent activation rates of substituted benzimidazoles and biological in vitro correlates

1 reference

12 December 2020

Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion

1 reference

12 December 2020

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

1 reference

12 December 2020

Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders

1 reference

12 December 2020

Drug interaction studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study

1 reference

12 December 2020

Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism

1 reference

12 December 2020

Current indications for acid suppressants in dyspepsia

1 reference

12 December 2020

Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

1 reference

12 December 2020

The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly

1 reference

12 December 2020

Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole

1 reference

12 December 2020

Sites of Reaction of the Gastric H,K-ATPase with Extracytoplasmic Thiol Reagents

1 reference

12 December 2020

Helicobacter pylori-associated peptic ulcer disease in older patients: current management strategies

1 reference

12 December 2020

Survey of prescriptions for peptic ulcer drugs (ACT class AOB2) in Iceland

1 reference

12 December 2020

Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output

1 reference

12 December 2020

Oral phenytoin pharmacokinetics during omeprazole therapy

1 reference

12 December 2020

Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19.

1 reference

12 December 2020

An evidence-based appraisal of reflux disease management--the Genval Workshop Report

1 reference

12 December 2020

Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients

1 reference

12 December 2020

Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial

1 reference

12 December 2020

Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders

1 reference

12 December 2020

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group

1 reference

12 December 2020

Effects of clarithromycin on the metabolism of omeprazole in relation to CYP2C19 genotype status in humans

1 reference

12 December 2020

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

1 reference

12 December 2020

Omeprazole and the development of acute hepatitis

1 reference

12 December 2020

The Loiano-Monghidoro population-based study of Helicobacter pylori infection: prevalence by 13C-urea breath test and associated factors

1 reference

12 December 2020

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

12 December 2020

Pharmacokinetics of pantoprazole in man

1 reference

12 December 2020

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

1 reference

12 December 2020

Pharmacokinetic studies with esomeprazole, the (S)-isomer of omeprazole

1 reference

12 December 2020

Influence of lansoprazole treatment on diazepam plasma concentrations

1 reference

12 December 2020

A quantitative analysis of symptoms of non-ulcer dyspepsia as related to age, pathology, and Helicobacter infection

1 reference

12 December 2020

Drug interaction: omeprazole and phenprocoumon

1 reference

12 December 2020

Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease

1 reference

12 December 2020

Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection

1 reference

12 December 2020

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study

1 reference

12 December 2020

Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months

1 reference

12 December 2020

Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily

1 reference

12 December 2020

Effect of age and Helicobacter pylori infection on gastric acid secretion

1 reference

12 December 2020

Pharmacokinetic study of esomeprazole in the elderly

1 reference

12 December 2020

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

12 December 2020

Atrophic gastritis during long-term omeprazole therapy affects serum vitamin B12 levels

1 reference

12 December 2020

Is laparoscopic antireflux surgery for gastroesophageal reflux disease in the elderly safe and effective?

1 reference

12 December 2020

Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal damage in elderly subjects

1 reference

12 December 2020

1 reference

12 December 2020

Gastric Acidity in Older Adults

1 reference

12 December 2020

Role of acid suppressants in intensive care medicine

1 reference

12 December 2020

Prevalence and characteristics of symptomatic gastroesophageal reflux disease in the elderly

1 reference

12 December 2020

Review article: rabeprazole's tolerability profile in clinical trials

1 reference

12 December 2020

Omeprazole-induced interstitial nephritis

1 reference

12 December 2020

The Second Canadian Gastroesophageal Reflux Disease Consensus: moving forward to new concepts

1 reference

12 December 2020

Appropriate acid suppression for optimal healing of duodenal ulcer and gastro-oesophageal reflux disease

1 reference

12 December 2020

Laparoscopic Nissen fundoplication: where do we stand?

1 reference

12 December 2020

Review article: the control of gastric acid and Helicobacter pylori eradication.

1 reference

12 December 2020

The Cohort Effect and Helicobacter pylori

1 reference

12 December 2020

Importance of pH control in the management of GERD.

1 reference

12 December 2020

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

12 December 2020

CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole

1 reference

12 December 2020

Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers?

1 reference

12 December 2020

Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis

1 reference

12 December 2020

Peptic disease in elderly patients

1 reference

12 December 2020

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors

1 reference

12 December 2020

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

1 reference

12 December 2020

Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes

1 reference

12 December 2020

Gastro-Oesophageal reflux in the elderly: role of drug therapy in management

1 reference

12 December 2020

Lack of pantoprazole drug interactions in man: an updated review.

1 reference

12 December 2020

The importance of interleukin 1beta in Helicobacter pylori associated disease

1 reference

12 December 2020

Management of dyspepsia: report of a working party

1 reference

12 December 2020

Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen

1 reference

12 December 2020

Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study

1 reference

12 December 2020

Pharmacological interventions for non-ulcer dyspepsia

1 reference

12 December 2020

Safety experience from long-term treatment with omeprazole

1 reference

12 December 2020

Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?

1 reference

12 December 2020

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders

1 reference

12 December 2020

Laparoscopic antireflux surgery in the elderly

1 reference

12 December 2020

Review article: role of proton pump inhibitors in non-H. pylori-related ulcers

1 reference

12 December 2020

Single and multiple dose pharmacokinetics of lansoprazole in elderly subjects

1 reference

12 December 2020

Reducing community dyspepsia drug costs: a controlled trial

1 reference

12 December 2020

Lansoprazole-induced hepatitis

1 reference

12 December 2020

Increased numbers of women, older individuals, and Blacks receive health care for dyspepsia in the United States

1 reference

12 December 2020

Appropriateness of omeprazole prescribing in Quebec's senior population

1 reference

12 December 2020

Omeprazole and CYP2C19 polymorphism: effects of long-term treatment on gastrin, pepsinogen I, and chromogranin A in patients with acid related disorders

1 reference

12 December 2020

Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro.

1 reference

12 December 2020

Onset of symptom relief with rabeprazole: a community-based, open-label assessment of patients with erosive oesophagitis

1 reference

12 December 2020

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

1 reference

12 December 2020

10.2165/00002512-200219120-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1009628742

0 references

1 reference